165 related articles for article (PubMed ID: 32407908)
21. Transformer-Based Deep-Learning Algorithm for Discriminating Demyelinating Diseases of the Central Nervous System With Neuroimaging.
Huang C; Chen W; Liu B; Yu R; Chen X; Tang F; Liu J; Lu W
Front Immunol; 2022; 13():897959. PubMed ID: 35774780
[TBL] [Abstract][Full Text] [Related]
22. An Abnormally High Neutrophil-to-Lymphocyte Ratio Is Not an Independent Outcome Predictor in AQP4-IgG-Positive NMOSD.
Carnero Contentti E; Delgado-García G; Criniti J; López PA; Pettinicchi JP; Cristiano E; Miguez J; Correa-Díaz EP; Álvarez Pucha MO; Miño Zambrano JE; Gómez-Figueroa E; Rivas-Alonso V; Flores-Rivera J; Tkachuk V; Caride A; Rojas JI
Front Immunol; 2021; 12():628024. PubMed ID: 33717149
[TBL] [Abstract][Full Text] [Related]
23. MRI Patterns Distinguish AQP4 Antibody Positive Neuromyelitis Optica Spectrum Disorder From Multiple Sclerosis.
Clarke L; Arnett S; Bukhari W; Khalilidehkordi E; Jimenez Sanchez S; O'Gorman C; Sun J; Prain KM; Woodhall M; Silvestrini R; Bundell CS; Abernethy DA; Bhuta S; Blum S; Boggild M; Boundy K; Brew BJ; Brownlee W; Butzkueven H; Carroll WM; Chen C; Coulthard A; Dale RC; Das C; Fabis-Pedrini MJ; Gillis D; Hawke S; Heard R; Henderson APD; Heshmat S; Hodgkinson S; Kilpatrick TJ; King J; Kneebone C; Kornberg AJ; Lechner-Scott J; Lin MW; Lynch C; Macdonell RAL; Mason DF; McCombe PA; Pereira J; Pollard JD; Ramanathan S; Reddel SW; Shaw CP; Spies JM; Stankovich J; Sutton I; Vucic S; Walsh M; Wong RC; Yiu EM; Barnett MH; Kermode AGK; Marriott MP; Parratt JDE; Slee M; Taylor BV; Willoughby E; Brilot F; Vincent A; Waters P; Broadley SA
Front Neurol; 2021; 12():722237. PubMed ID: 34566866
[TBL] [Abstract][Full Text] [Related]
24. Frequency of Aquaporin-4 Immunoglobulin G in Longitudinally Extensive Transverse Myelitis With Antiphospholipid Antibodies.
Guerra H; Pittock SJ; Moder KG; Fryer JP; Gadoth A; Flanagan EP
Mayo Clin Proc; 2018 Sep; 93(9):1299-1304. PubMed ID: 29655487
[TBL] [Abstract][Full Text] [Related]
25. Brain and spinal MRI features distinguishing MS from different AQP4 antibody serostatus NMOSD at disease onset in a cohort of Latin American patients.
Carnero Contentti E; Marques VD; Soto de Castillo I; Tkachuk V; Barreira AA; Caride A; Castillo MC; Cristiano E; de Aquino Cruz C; Braga Diégues Serva G; Santos ACD; Labarca R; Lavigne Moreira C; López PA; Miguez J; Molina O; Pettinicchi JP; Rojas JI
Mult Scler; 2020 Jul; 26(8):945-954. PubMed ID: 31124748
[TBL] [Abstract][Full Text] [Related]
26. Specific MRI findings help distinguish acute transverse myelitis of Neuromyelitis Optica from spinal cord infarction.
Kister I; Johnson E; Raz E; Babb J; Loh J; Shepherd TM
Mult Scler Relat Disord; 2016 Sep; 9():62-7. PubMed ID: 27645347
[TBL] [Abstract][Full Text] [Related]
27. Memantine ameliorates motor impairments and pathologies in a mouse model of neuromyelitis optica spectrum disorders.
Yick LW; Tang CH; Ma OK; Kwan JS; Chan KH
J Neuroinflammation; 2020 Aug; 17(1):236. PubMed ID: 32782018
[TBL] [Abstract][Full Text] [Related]
28. [Clinical presentations of neuromyelitis optica spectrum disorders with ultra-longitudinally extensive transverse myelitis].
Huang X; Xu FF; Qian HR; Lei X; Qi XK; Xia DY
Zhonghua Yi Xue Za Zhi; 2018 Jun; 98(21):1658-1663. PubMed ID: 29925142
[No Abstract] [Full Text] [Related]
29. Paraneoplastic AQP4-IgG-Seropositive Neuromyelitis Optica Spectrum Disorder Associated With Teratoma: A Case Report and Literature Review.
Ikeguchi R; Shimizu Y; Shimomura A; Suzuki M; Shimoji K; Motohashi T; Yamamoto T; Shibata N; Kitagawa K
Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34285095
[TBL] [Abstract][Full Text] [Related]
30. Contribution of spinal cord biopsy to diagnosis of aquaporin-4 antibody positive neuromyelitis optica spectrum disorder.
Ringelstein M; Metz I; Ruprecht K; Koch A; Rappold J; Ingwersen J; Mathys C; Jarius S; Brück W; Hartung HP; Paul F; Aktas O;
Mult Scler; 2014 Jun; 20(7):882-8. PubMed ID: 24192218
[TBL] [Abstract][Full Text] [Related]
31. A comparison between spinal cord infarction and neuromyelitis optica spectrum disorders: Clinical and MRI studies.
Hsu JL; Cheng MY; Liao MF; Hsu HC; Weng YC; Chang KH; Chang HS; Kuo HC; Huang CC; Lyu RK; Lin KJ; Ro LS
Sci Rep; 2019 May; 9(1):7435. PubMed ID: 31092838
[TBL] [Abstract][Full Text] [Related]
32. Aquaporin-4 antibody-positive myelitis initially biopsied for suspected spinal cord tumors: diagnostic considerations.
Sato DK; Misu T; Rocha CF; Callegaro D; Nakashima I; Aoki M; Fujihara K; Lana-Peixoto MA
Mult Scler; 2014 Apr; 20(5):621-6. PubMed ID: 24029914
[TBL] [Abstract][Full Text] [Related]
33. [The role of aquaporin 4 antibody in the injury of retinal microstructure in neuromyelitis optica spectrum disorders].
Wang ZW; Wang QQ; Diao DW; Guo QF; Qi XK
Zhonghua Nei Ke Za Zhi; 2018 Jun; 57(6):435-439. PubMed ID: 29925129
[No Abstract] [Full Text] [Related]
34. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
[TBL] [Abstract][Full Text] [Related]
35. [Clinical analysis of neuromyelitis optica spectrum disorders in childhood].
Zhou J; Zhang Y; Ji TY; Jin YW; Bao XH; Zhang YH; Xiong H; Chang XZ; Jiang YW; Wu Y
Zhonghua Er Ke Za Zhi; 2019 Feb; 57(2):118-124. PubMed ID: 30695886
[No Abstract] [Full Text] [Related]
36. Comparison of brain and spinal cord magnetic resonance imaging features in neuromyelitis optica spectrum disorders patients with or without aquaporin-4 antibody.
Fan M; Fu Y; Su L; Shen Y; Wood K; Yang L; Liu Y; Shi FD
Mult Scler Relat Disord; 2017 Apr; 13():58-66. PubMed ID: 28427704
[TBL] [Abstract][Full Text] [Related]
37. Predictive value of MRI parameters in severity and recovery of first-episode myelitis in aquaporin-4 antibody disease.
Murchison A; Kitley J; Leite MI; Küker W; Palace J
J Neurol Sci; 2015 Aug; 355(1-2):49-53. PubMed ID: 26026944
[TBL] [Abstract][Full Text] [Related]
38. A prospective study on tryptophan immunoadsorption in AQP4 antibody-positive neuromyelitis optica spectrum disorders.
Liu J; Zhou R; Gong Y; Ding X; Huang Q; Zhang Y; Feng Y; Wang D; Zhou H; Ma Y; Zhang X; Zhou Y
J Clin Apher; 2022 Jun; 37(3):237-244. PubMed ID: 35104012
[TBL] [Abstract][Full Text] [Related]
39. Neuromyelitis Optica (Devic's Syndrome): an Appraisal.
Crout TM; Parks LP; Majithia V
Curr Rheumatol Rep; 2016 Aug; 18(8):54. PubMed ID: 27402111
[TBL] [Abstract][Full Text] [Related]
40. Short-segment transverse myelitis lesions in a cohort of Latin American patients with neuromyelitis optica spectrum disorders.
Carnero Contentti E; Daccach Marques V; Soto de Castillo I; Tkachuk V; Antunes Barreira A; Armas E; Chiganer E; de Aquino Cruz C; Di Pace JL; Hryb JP; Lavigne Moreira C; Lessa C; Molina O; Perassolo M; Soto A; Caride A
Spinal Cord; 2018 Oct; 56(10):949-954. PubMed ID: 29789706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
